UNC Metastatic Cancer Radiation Therapy Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUNC Lineberger Comprehensive Cancer Center
About this trial
The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Subjects with metastatic cancer receiving palliative radiation therapy at the University of North Carolina Chapel Hill.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Radiation therapy
RadiationSubjects with metastatic cancer receive radiation therapy.
Treatment groups
2,000 Participants
are divided into 1 treatment groupGroup A: Palliative radiation therapy1 intervention
Trial outcomes
Primary outcomes
1
Clinical Data
Clinical data and radiological assessments from participants with metastatic cancer receiving radiation therapy as a part of the standard of care will be collected.
Time frame
Up to 1 monthSecondary outcomes
1
Patient reported outcomes (PRO)
Patient reported outcomes (PRO) from participants will be collected at different time points.
Time frame
Baseline, 1 month, 3 months, 6 months, 9 months, and 12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov